CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

David Li

President, Chief Executive Officer & Director, INGEVITY CORP

Search every verified David Li interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. David Li, President and CEO of Ingevity, presented at the Gabelli 17th Annual Specialty Chemicals Symposium on March 19, 2026, where he discussed the company's ongoing strategic transformation. He noted that Ingevity had completed the sale of its performance chemicals industrial specialties product line and North Charleston CTO refinery at the beginning of the year, and had initiated a sales process for its advanced polymer technology segment and road markings business. Li stated that post-divestitures, the company expects to have $1 billion of deployable cash over the next two years from core operations and divestment proceeds. During the presentation, Li described Ingevity as a "cashflow juggernaut," outlining plans to use proceeds for organic growth, debt reduction, and share buybacks. He reported that the company had reduced its leverage from nearly four times to over a full turn lower in less than a year, and projected free cash flow of $225 to $250 million. Li also highlighted the company's profitability, referencing "50 plus percent EBITDA margins" and expressing a "healthy paranoia" about competitive threats to that margin. He emphasized expectations for double-digit EPS growth through capital allocation, including debt paydown and share repurchases.

Recent appearances

  • Ingevity Corporation (NYSE:NGVT) Dave Li, Pres. & CEO - Gabelli 17th Specialty Chemicals Symposium

    April 27, 2026 · 📺 GabelliTV

    Ingevity Corporation (NYSE:NGVT) - Dave Li, President & CEO - presents at the Gabelli 17th Annual Specialty Chemicals Symposium held on March 19th, 2026. To learn more about Gabelli Funds' fundamental, research-driven approach to investing, visit https://m.gabelli.com/gtv_cu or email [email protected]. Connect with Gabelli Funds: • LinkedIn -   / investgabelli   • X - https://x.com/InvestGabelli • Instagram -   / investgabelli   • Facebook -   / investgabelli   http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554)

    Watch on YouTube ↗

  • Broad-MIT Seminar Series in Chemical Biology: David Liu (2022)

    February 27, 2023 · 📺 Broad Institute

    Broad-MIT Seminar Series in Chemical Biology October 24, 2022 MIT David Liu Base Editing and Prime Editing: Precise Chemistry on the Genome without Double-Strand DNA Breaks Full Abstract: In this lecture, I describe the development and therapeutic application of two precision gene editing technologies that install or correct targeted mutations without requiring double-strand DNA breaks, thereby minimizing undesired consequences of chromosomal cleavage such as translocations, p53 activation, chromothripsis, and uncontrolled mixtures of indels. We developed base editors, proteins that directly…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →